☆ 4.3 Editorial Material

Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk - No

MULTIPLE SCLEROSIS JOURNAL (2022)

Journal

MULTIPLE SCLEROSIS JOURNAL

Volume 28, Issue 8, Pages 1175-1177

Publisher

SAGE PUBLICATIONS LTD

DOI: 10.1177/13524585221091404

Keywords

-

Categories

Clinical Neurology Neurosciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.